Download Files:
PDE9-IN-1
SKU
HY-126137-10 mg
Category Reference compound
Tags Metabolic Enzyme/Protease, Neurological Disease, Phosphodiesterase (PDE)
$280 – $1,700
Products Details
Product Description
– PDE9-IN-1 is a potent, selective, and orally bioavailable phosphodiesterase-9A (PDE9A) Inhibitor with an IC50 of 8.7 nM[1].
Web ID
– HY-126137
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C17H23FN6O2
References
– [1]Wu Y, et al. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia. J Med Chem. 2019 Apr 25;62(8):4218-4224.
CAS Number
– 2305087-92-5
Molecular Weight
– 362.40
Compound Purity
– 99.70
SMILES
– O=C1C2=C(N(C3CCCC3)N=C2)N=C(N[C@H](C)C(N4CC[C@H](F)C4)=O)N1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Isoform
– PDE9
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.